Kyrre E. Emblem
Kyrre E. Emblem
Oslo University Hospital, Oslo, Norway / Massachusetts General Hospital, Boston, MA, USA
Verifisert e-postadresse på rr-research.no - Startside
Sitert av
Sitert av
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
TT Batchelor, ER Gerstner, KE Emblem, DG Duda, J Kalpathy-Cramer, ...
Proceedings of the national academy of sciences 110 (47), 19059-19064, 2013
Brain-wide glymphatic enhancement and clearance in humans assessed with MRI
G Ringstad, LM Valnes, AM Dale, AH Pripp, SAS Vatnehol, KE Emblem, ...
JCI insight 3 (13), 2018
Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion
AG Sorensen, KE Emblem, P Polaskova, D Jennings, H Kim, ...
Cancer research 72 (2), 402-407, 2012
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy
KE Emblem, K Mouridsen, A Bjornerud, CT Farrar, D Jennings, RJH Borra, ...
Nature medicine 19 (9), 1178-1183, 2013
Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes
PK Eide, SAS Vatnehol, KE Emblem, G Ringstad
Scientific reports 8 (1), 7194, 2018
Glioma Grading by Using Histogram Analysis of Blood Volume Heterogeneity from MR-derived Cerebral Blood Volume Maps1
KE Emblem, B Nedregaard, T Nome, P Due-Tonnessen, JK Hald, ...
Radiology 247 (3), 808-817, 2008
Advanced magnetic resonance imaging of the physical processes in human glioblastoma
J Kalpathy-Cramer, ER Gerstner, KE Emblem, OC Andronesi, B Rosen
Cancer research 74 (17), 4622-4637, 2014
Lessons from anti–vascular endothelial growth factor and anti–vascular endothelial growth factor receptor trials in patients with glioblastoma
C Lu-Emerson, DG Duda, KE Emblem, JW Taylor, ER Gerstner, ...
Journal of Clinical Oncology 33 (10), 1197, 2015
A fully automated method for quantitative cerebral hemodynamic analysis using DSC–MRI
A Bjørnerud, KE Emblem
Journal of Cerebral Blood Flow & Metabolism 30 (5), 1066-1078, 2010
Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium
G Seano, HT Nia, KE Emblem, M Datta, J Ren, S Krishnan, J Kloepper, ...
Nature biomedical engineering 3 (3), 230-245, 2019
T1- and T*2-Dominant Extravasation Correction in DSC-MRI: Part I—Theoretical Considerations and Implications for Assessment of Tumor Hemodynamic Properties
A Bjornerud, AG Sorensen, K Mouridsen, KE Emblem
Journal of Cerebral Blood Flow & Metabolism 31 (10), 2041-2053, 2011
A generic support vector machine model for preoperative glioma survival associations
KE Emblem, MC Pinho, FG Zöllner, P Due-Tonnessen, JK Hald, ...
Radiology 275 (1), 228-234, 2015
Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly
A Heck, KE Emblem, O Casar-Borota, J Bollerslev, G Ringstad
Endocrine 52, 333-343, 2016
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
J Kalpathy-Cramer, V Chandra, X Da, Y Ou, KE Emblem, A Muzikansky, ...
Journal of neuro-oncology 131, 603-610, 2017
SVM-based glioma grading: optimization by feature reduction analysis
FG Zöllner, KE Emblem, LR Schad
Zeitschrift für medizinische Physik 22 (3), 205-214, 2012
Automatic glioma characterization from dynamic susceptibility contrast imaging: Brain tumor segmentation using knowledge‐based fuzzy clustering
KE Emblem, B Nedregaard, JK Hald, T Nome, P Due‐Tonnessen, ...
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009
Histogram analysis of MR imaging–derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes
KE Emblem, D Scheie, P Due-Tonnessen, B Nedregaard, T Nome, ...
American journal of neuroradiology 29 (9), 1664-1670, 2008
A fully automated deep learning network for brain tumor segmentation
CGB Yogananda, BR Shah, M Vejdani-Jahromi, SS Nalawade, ...
Tomography 6 (2), 186-193, 2020
Vessel calibre—a potential MRI biomarker of tumour response in clinical trials
KE Emblem, CT Farrar, ER Gerstner, TT Batchelor, RJH Borra, BR Rosen, ...
Nature reviews Clinical oncology 11 (10), 566-584, 2014
Bevacizumab reduces permeability and concurrent temozolomide delivery in a subset of patients with recurrent glioblastoma
ER Gerstner, KE Emblem, K Chang, B Vakulenko-Lagun, YF Yen, ...
Clinical Cancer Research 26 (1), 206-212, 2020
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20